GB0900727D0 - Haemostatic agent and uses thereof - Google Patents

Haemostatic agent and uses thereof

Info

Publication number
GB0900727D0
GB0900727D0 GBGB0900727.9A GB0900727A GB0900727D0 GB 0900727 D0 GB0900727 D0 GB 0900727D0 GB 0900727 A GB0900727 A GB 0900727A GB 0900727 D0 GB0900727 D0 GB 0900727D0
Authority
GB
United Kingdom
Prior art keywords
haemostatic agent
haemostatic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0900727.9A
Other versions
GB2466979A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BAKER SIMON J
Original Assignee
BAKER SIMON J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BAKER SIMON J filed Critical BAKER SIMON J
Priority to GB0900727A priority Critical patent/GB2466979A/en
Publication of GB0900727D0 publication Critical patent/GB0900727D0/en
Publication of GB2466979A publication Critical patent/GB2466979A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
GB0900727A 2009-01-19 2009-01-19 Porous ceramic compositions for use as haemostatic agents Withdrawn GB2466979A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0900727A GB2466979A (en) 2009-01-19 2009-01-19 Porous ceramic compositions for use as haemostatic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0900727A GB2466979A (en) 2009-01-19 2009-01-19 Porous ceramic compositions for use as haemostatic agents

Publications (2)

Publication Number Publication Date
GB0900727D0 true GB0900727D0 (en) 2009-03-04
GB2466979A GB2466979A (en) 2010-07-21

Family

ID=40445918

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0900727A Withdrawn GB2466979A (en) 2009-01-19 2009-01-19 Porous ceramic compositions for use as haemostatic agents

Country Status (1)

Country Link
GB (1) GB2466979A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114555098A (en) * 2019-08-19 2022-05-27 喜乐医疗器材股份有限公司 Hemostatic devices and methods

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113679877B (en) * 2021-08-13 2022-10-14 中国科学院上海硅酸盐研究所 Hydroxyapatite super-long nanowire hemostatic aerogel and preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374659D1 (en) * 1983-02-03 1988-01-07 Ethicon Inc Paste for hemostasis and for temporary relief of defects in the traumatism of bones
CN1064257C (en) * 1998-02-23 2001-04-11 静缘 External use hemostatic powder
JP2004026653A (en) * 2002-03-04 2004-01-29 Mitsuru Akashi Hydroxyapatite-polymer composite hemostatic composition
US6992233B2 (en) * 2002-05-31 2006-01-31 Medafor, Inc. Material delivery system
US7858123B2 (en) * 2005-04-04 2010-12-28 The Regents Of The University Of California Inorganic materials for hemostatic modulation and therapeutic wound healing
CN101036591A (en) * 2005-11-07 2007-09-19 雷蒙德·J·休伊 Device for supplying molecular sieve material for blood clot formation
WO2008112230A1 (en) * 2007-03-12 2008-09-18 Thomas Lally Hemostatic bio-material composition and method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114555098A (en) * 2019-08-19 2022-05-27 喜乐医疗器材股份有限公司 Hemostatic devices and methods

Also Published As

Publication number Publication date
GB2466979A (en) 2010-07-21

Similar Documents

Publication Publication Date Title
GB0914644D0 (en) Novel agents and uses thereof
LT3964502T (en) Psma-targeting compounds and uses thereof
AP3106A (en) Antiparisitic dihydroazole compounds and compositions comprising same
IL210804A (en) Benzylidenehydrazides and uses thereof
GB0905290D0 (en) Multilayer compositions and dressings
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
LT2456467T (en) Epsilon-polylysine conjugates and use thereof
ZA201201259B (en) Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
IL220526A0 (en) Kokumi-imparting agent
GB0903299D0 (en) Composition and methods
IL220527A0 (en) Kokumi-imparting agent
EP2291377A4 (en) Imidazopyrimidinones and uses thereof
ZA201103456B (en) Leukolectins and uses thereof
PL2247601T3 (en) Thiazopyrimidinones and uses thereof
EP2490536A4 (en) Compositions and processes
GB0902429D0 (en) Compositions and their use
GB0902173D0 (en) Compounds and their use
GB0912744D0 (en) Methods and uses
GB0901494D0 (en) Compositions and Methods
GB0922510D0 (en) Compound and use
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
SI2246181T1 (en) Compound material and its use
GB0900727D0 (en) Haemostatic agent and uses thereof
GB0909792D0 (en) Composition and uses thereof
GB0905525D0 (en) Compounds and uses

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)